SCHEMBL17412410

SCHEMBL17412410

Clc1cc(-c2cc3ccccc3c3ccccc23)nc(-c2ccccc2)n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.51
CYP11B1 P15538 1/20 0.45
ATP4A P20648 1/20 0.44
ATP4B P51164 1/20 0.44
HSP90AA1 P07900 2/20 0.44
HSP90AB1 P08238 2/20 0.44
KDM4E B2RXH2 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.43
POLB P06746 2/20 0.43
CTDSP1 Q9GZU7 1/20 0.43
MEN1 O00255 6/20 0.41
KMT2A Q03164 6/20 0.41
MAPT P10636 4/20 0.41
MCOLN3 Q8TDD5 1/20 0.41
HTT P42858 2/20 0.40
ADORA2A P29274 1/20 0.39
ADORA1 P30542 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17412415 0.97 LMNA (0.49) LMNACYP11B1ATP4AATP4BHSP90AA1
SCHEMBL22274009 0.92 LMNA (0.47) LMNACYP11B1ATP4AATP4BHSP90AA1
SCHEMBL22249382 0.89 KDM4E (0.47) LMNACYP11B1ATP4AATP4BHSP90AA1
SCHEMBL17412430 0.88 HSP90AA1 (0.41) LMNACYP11B1HSP90AA1HSP90AB1KDM4E
SCHEMBL23802655 0.88 LMNA (0.46) LMNACYP11B1ATP4AATP4BHSP90AA1
SCHEMBL31398855 0.88 LMNA (0.46) LMNACYP11B1ATP4AATP4BHSP90AA1
SCHEMBL17412390 0.87 KDM4E (0.51) LMNACYP11B1ATP4AATP4BHSP90AA1
SCHEMBL18804087 0.85 MEN1 (0.49) LMNACYP11B1KDM4EL3MBTL1POLB
SCHEMBL19271374 0.85 MEN1 (0.53) LMNACYP11B1KDM4EL3MBTL1MEN1
SCHEMBL22274622 0.84 LMNA (0.43) LMNACYP11B1ATP4AATP4BHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230399329-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR FORMING ORGANIC LAYER LT MATERIALS CO., LTD. (KR) 2023-12-14 US disclosed
US-20230399329-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR FORMING ORGANIC LAYER LT MATERIALS CO., LTD. (KR) 2023-12-14 US disclosed
WO-2016003225-A2 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING SAME 덕산네오룩스 주식회사 2016-01-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230399329-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR FORMING ORGANIC LAYER CRY1, ORC3, ODC1 LMNA 1313/4885CYP11B1 162/4885ATP4A 3220/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.